Primary lateral sclerosis: consensus diagnostic criteria

Martin R Turner, Richard J Barohn, Philippe Corcia, John K Fink, Matthew B Harms, Matthew C Kiernan, John Ravits, Vincenzo Silani, Zachary Simmons, Jeffrey Statland, Leonard H van den Berg, Delegates of the 2nd International PLS Conference, Hiroshi Mitsumoto, Senda Ajroud-Driss, Jinsy A Andrews, Suma Babu, Peter Bede, Michael Benatar, Sheena Chew, Robin Conwit, Merit Cudkowicz, Mamede de Carvalho, Vivian E Drory, Lauren Elman, J Americo M Fernandes, Dominic Ferrey, Eoin Finegan, Mary Kay Floeter, Christina N Fournier, Raghav Govindarajan, Volkan Granit, Orla Hardiman, Ghazala Hayat, Terry D Heiman-Patterson, Annemarie Hübers, Edward D Huey, Omar Jawdat, Osamu Kano, Yaz Y Kisanuki, Ian Mackenzie, David Marren, Mitsuya Morita, Jennifer Murphy, Sharon Nations, Björn Oskarsson, Sabrina Paganoni, Erik P Pioro, Seth L Pullman, Kourosh Rezania, Guy Rouleau, Stephen Scelsa, Nailah Siddique, Juan Solano, Marka van Blitterswijk, David Walk, James Wymer, Cuiping Zhao, Dale Lange, Martin R Turner, Richard J Barohn, Philippe Corcia, John K Fink, Matthew B Harms, Matthew C Kiernan, John Ravits, Vincenzo Silani, Zachary Simmons, Jeffrey Statland, Leonard H van den Berg, Delegates of the 2nd International PLS Conference, Hiroshi Mitsumoto, Senda Ajroud-Driss, Jinsy A Andrews, Suma Babu, Peter Bede, Michael Benatar, Sheena Chew, Robin Conwit, Merit Cudkowicz, Mamede de Carvalho, Vivian E Drory, Lauren Elman, J Americo M Fernandes, Dominic Ferrey, Eoin Finegan, Mary Kay Floeter, Christina N Fournier, Raghav Govindarajan, Volkan Granit, Orla Hardiman, Ghazala Hayat, Terry D Heiman-Patterson, Annemarie Hübers, Edward D Huey, Omar Jawdat, Osamu Kano, Yaz Y Kisanuki, Ian Mackenzie, David Marren, Mitsuya Morita, Jennifer Murphy, Sharon Nations, Björn Oskarsson, Sabrina Paganoni, Erik P Pioro, Seth L Pullman, Kourosh Rezania, Guy Rouleau, Stephen Scelsa, Nailah Siddique, Juan Solano, Marka van Blitterswijk, David Walk, James Wymer, Cuiping Zhao, Dale Lange

Abstract

Primary lateral sclerosis (PLS) is a neurodegenerative disorder of the adult motor system. Characterised by a slowly progressive upper motor neuron syndrome, the diagnosis is clinical, after exclusion of structural, neurodegenerative and metabolic mimics. Differentiation of PLS from upper motor neuron-predominant forms of amyotrophic lateral sclerosis remains a significant challenge in the early symptomatic phase of both disorders, with ongoing debate as to whether they form a clinical and histopathological continuum. Current diagnostic criteria for PLS may be a barrier to therapeutic development, requiring long delays between symptom onset and formal diagnosis. While new technologies sensitive to both upper and lower motor neuron involvement may ultimately resolve controversies in the diagnosis of PLS, we present updated consensus diagnostic criteria with the aim of reducing diagnostic delay, optimising therapeutic trial design and catalysing the development of disease-modifying therapy.

Conflict of interest statement

Competing interests: MRT is on the Scientific Advisory Board for Orphazyme, has been a paid consultant for Genentech Inc. (2017) and anonymous clients separately through GLG Consulting on the topic of ALS diagnosis, management and biomarker development. He received neurofilament assay kits in-kind from Euroimmun UK (2018).PC has reveived honoraria from Biogen & Cytokinetics. ZS has received honoraria from Wiley, Cytokinetics & Biohaven. HM is on the Advisory Board of Mitsubishi-Tanabe & Biohaven.

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ.

Figures

Figure 1
Figure 1
Diffusion tensor imaging and fluorodeoxyglucose (FDG) positron emission tomography (PET) findings in cases of primary lateral sclerosis (PLS). Mean diffusivity in the mid-portion of the corpus callosum is increased in cases of PLS compared with amyotrophic lateral sclerosis (row A, PLS vs ALS group findings highlighted on axial, coronal and sagittal views of the white matter tract skeleton; with kind permission of the author, see Iwata et al37). Focal hypometabolism may be seen in the primary motor cortices in PLS (row B, FDG PET z-score images in the right sagittal, left sagittal and axial planes; with kind permission of the author, see Claassen et al35). Neither of these techniques yet has sufficient sensitivity or specificity to be applied in isolation for the diagnosis of PLS.

References

    1. Stark FM, Moersch FP. Primary lateral sclerosis: a distinct clinical entity. J Nerv Ment Dis 1945;102:332–7.
    1. Chiò A, Calvo A, Moglia C, et al. . Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry 2011;82:740–6. 10.1136/jnnp.2010.235952
    1. D'Amico E, Pasmantier M, Lee Y-W, et al. . Clinical evolution of pure upper motor neuron disease/dysfunction (PUMMD). Muscle Nerve 2013;47:28–32. 10.1002/mus.23496
    1. Pringle CE, Hudson AJ, Munoz DG, et al. . Primary lateral sclerosis. clinical features, neuropathology and diagnostic criteria. Brain 1992;115:495–520. 10.1093/brain/115.2.495
    1. Gordon PH, Cheng B, Katz IB, et al. . The natural history of primary lateral sclerosis. Neurology 2006;66:647–53. 10.1212/01.wnl.0000200962.94777.71
    1. Tan C-F, Kakita A, Piao Y-S, et al. . Primary lateral sclerosis: a rare upper-motor-predominant form of amyotrophic lateral sclerosis often accompanied by frontotemporal lobar degeneration with ubiquitinated neuronal inclusions? report of an autopsy case and a review of the literature. Acta Neuropathol 2003;105:615–20. 10.1007/s00401-003-0687-0
    1. Dickson DW, Josephs KA, Amador-Ortiz C. Tdp-43 in differential diagnosis of motor neuron disorders. Acta Neuropathol 2007;114:71–9. 10.1007/s00401-007-0234-5
    1. Singer MA, Statland JM, Wolfe GI, et al. . Primary lateral sclerosis. Muscle Nerve 2007;35:291–302. 10.1002/mus.20728
    1. Zhai P, Pagan F, Statland J, et al. . Primary lateral sclerosis: a heterogeneous disorder composed of different subtypes? Neurology 2003;60:1258–65. 10.1212/01.WNL.0000058900.02672.D2
    1. Norlinah IM, Bhatia KP, Østergaard K, et al. . Primary lateral sclerosis mimicking atypical parkinsonism. Mov Disord 2007;22:2057–62. 10.1002/mds.21645
    1. Mabuchi N, Watanabe H, Atsuta N, et al. . Primary lateral sclerosis presenting parkinsonian symptoms without nigrostriatal involvement. J Neurol Neurosurg Psychiatry 2004;75:1768–71. 10.1136/jnnp.2003.035212
    1. de Vries BS, Rustemeijer LMM, Bakker LA, et al. . Cognitive and behavioural changes in PLS and PMA:challenging the concept of restricted phenotypes. J Neurol Neurosurg Psychiatry 2019;90:141–7. 10.1136/jnnp-2018-318788
    1. Agarwal S, Highton-Williamson E, Caga J, et al. . Primary lateral sclerosis and the amyotrophic lateral sclerosis–frontotemporal dementia spectrum. J Neurol 2018;265:1819–28. 10.1007/s00415-018-8917-5
    1. Turner MR. The reunification of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2019;90:122–3. 10.1136/jnnp-2018-319470
    1. Mills CK. Unilateral ascending paralysis and unilateral descending paralysis. their clinical varieties and their pathological causes. JAMA 1906;20:1638–45.
    1. Keegan BM, Kaufmann TJ, Weinshenker BG, et al. . Progressive solitary sclerosis: gradual motor impairment from a single CNS demyelinating lesion. Neurology 2016;87:1713–9. 10.1212/WNL.0000000000003235
    1. Gastaut JL, Bartolomei F. Mills' syndrome: ascending (or descending) progressive hemiplegia: a hemiplegic form of primary lateral sclerosis? J Neurol Neurosurg Psychiatry 1994;57:1280–1. 10.1136/jnnp.57.10.1280
    1. Kuipers-Upmeijer J, de Jager AE, Hew JM. Primary lateral sclerosis: clinical, neurophysiological, and magnetic resonance findings. JNeurolNeurosurgPsychiatry 2001;71:615–20. 10.1136/jnnp.71.5.615
    1. Le Forestier N, Maisonobe T, Piquard A, et al. . Does primary lateral sclerosis exist? A study of 20 patients and a review of the literature. Brain 2001;124:1989–99. 10.1093/brain/124.10.1989
    1. Singer MA, Kojan S, Barohn RJ, et al. . Primary lateral sclerosis: clinical and laboratory features in 25 patients. J Clin Neuromuscul Dis 2005;7:1–9. 10.1097/01.cnd.0000176974.61136.45
    1. Mitsumoto H, Nagy PL, Gennings C, et al. . Phenotypic and molecular analyses of primary lateral sclerosis. Neurol Genet 2015;1:e3 10.1212/01.NXG.0000464294.88607.dd
    1. Fournier CN, Murphy A, Loci L, et al. . Primary lateral sclerosis and early upper motor neuron disease: characteristics of a cross-sectional population. J Clin Neuromuscul Dis 2016;17:99–105. 10.1097/CND.0000000000000102
    1. Wais V, Rosenbohm A, Petri S, et al. . The concept and diagnostic criteria of primary lateral sclerosis. Acta Neurol Scand 2017;136:204–11. 10.1111/ane.12713
    1. Fink JK. Progressive spastic paraparesis: hereditary spastic paraplegia and its relation to primary and amyotrophic lateral sclerosis. Semin Neurol 2001;21:199–208. 10.1055/s-2001-15265
    1. Brugman F, Veldink JH, Franssen H, et al. . Differentiation of hereditary spastic paraparesis from primary lateral sclerosis in sporadic adult-onset upper motor neuron syndromes. Arch Neurol 2009;66:509–14. 10.1001/archneurol.2009.19
    1. Huynh W, Simon NG, Grosskreutz J, et al. . Assessment of the upper motor neuron in amyotrophic lateral sclerosis. Clinical Neurophysiology 2016;127:2643–60. 10.1016/j.clinph.2016.04.025
    1. Tsuji Y, Noto Y-ichi, Shiga K, et al. . A muscle ultrasound score in the diagnosis of amyotrophic lateral sclerosis. Clinical Neurophysiology 2017;128:1069–74. 10.1016/j.clinph.2017.02.015
    1. Noto Y-I, Shibuya K, Shahrizaila N, et al. . Detection of fasciculations in amyotrophic lateral sclerosis: the optimal ultrasound scan time. Muscle Nerve 2017;56:1068–71. 10.1002/mus.25607
    1. Tsugawa J, Dharmadasa T, Ma Y, et al. . Fasciculation intensity and disease progression in amyotrophic lateral sclerosis. Clin Neurophysiol 2018;129:2149–54. 10.1016/j.clinph.2018.07.015
    1. Geevasinga N, Menon P, Sue CM, et al. . Cortical excitability changes distinguish the motor neuron disease phenotypes from hereditary spastic paraplegia. Eur J Neurol 2015;22:826–58. 10.1111/ene.12669
    1. Fisher KM, Zaaimi B, Williams TL, et al. . Beta-Band intermuscular coherence: a novel biomarker of upper motor neuron dysfunction in motor neuron disease. Brain 2012;135:2849–64. 10.1093/brain/aws150
    1. Proudfoot M, van Ede F, Quinn A, et al. . Impaired corticomuscular and interhemispheric cortical beta oscillation coupling in amyotrophic lateral sclerosis. Clin Neurophysiol 2018;129:1479–89. 10.1016/j.clinph.2018.03.019
    1. Steinacker P, Feneberg E, Weishaupt J, et al. . Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients. J Neurol Neurosurg Psychiatry 2016;87:12–20. 10.1136/jnnp-2015-311387
    1. Thompson AG, Gray E, Bampton A, et al. . Csf chitinase proteins in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2019;90:1215–20. 10.1136/jnnp-2019-320442
    1. Claassen DO, Josephs KA, Peller PJ. The stripe of primary lateral sclerosis: focal primary motor cortex hypometabolism seen on fluorodeoxyglucose F18 positron emission tomography. Arch Neurol 2010;67:122–5. 10.1001/archneurol.2009.298
    1. Ciccarelli O, Behrens TE, Johansen-Berg H, et al. . Investigation of white matter pathology in ALS and PLS using tract-based spatial statistics. Hum Brain Mapp 2009;30:615–24. 10.1002/hbm.20527
    1. Iwata NK, Kwan JY, Danielian LE, et al. . White matter alterations differ in primary lateral sclerosis and amyotrophic lateral sclerosis. Brain 2011;134:2642–55. 10.1093/brain/awr178
    1. Finegan E, Chipika RH, Li Hi Shing S, et al. . The clinical and radiological profile of primary lateral sclerosis: a population-based study. J Neurol 2019;266:2718–33. 10.1007/s00415-019-09473-z
    1. Tu S, Menke RAL, Talbot K, et al. . Cerebellar tract alterations in PLS and ALS. Amyotroph Lateral Scler Frontotemporal Degener 2019;20:281–4. 10.1080/21678421.2018.1562554
    1. Fabes J, Matthews L, Filippini N, et al. . Quantitative FLAIR MRI in amyotrophic lateral sclerosis. Acad Radiol 2017;24:1187–94. 10.1016/j.acra.2017.04.008
    1. Schweitzer AD, Liu T, Gupta A, et al. . Quantitative susceptibility mapping of the motor cortex in amyotrophic lateral sclerosis and primary lateral sclerosis. AJR Am J Roentgenol 2015;204:1086–92. 10.2214/AJR.14.13459
    1. van der Burgh HK, Westeneng H-J, Meier JM, et al. . Cross-Sectional and longitudinal assessment of the upper cervical spinal cord in motor neuron disease. Neuroimage 2019;24:101984 10.1016/j.nicl.2019.101984

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere